Search Results
Site Search
Mayo Clinic Laboratory and pathology research roundup: September 19 - Insights
This week's research roundup feature: There is a need to develop safe and effective pharmacologic options for the treatment of celiac disease (CeD); however, consensus on the appropriate design and configuration of randomized controlled...
Mayo Clinic Laboratory and Pathology Research Roundup: May 21 - Insights
This week’s Research Roundup highlights the development and validation of a prostate cancer genomic signature that predicts early androgen deprivation therapy (ADT) treatment response following radical prostatectomy.
Mayo Clinic Laboratory and Pathology Research Roundup: June 18 - Insights
This week’s Research Roundup features highly discriminant methylated DNA markers for the non-endoscopic detection of Barrett's esophagus.
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...
Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS - Insights
By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial...
MCL - Neurology Specialty Testing Client Test Request - MC0767-02A
MCL - Neurology Specialty Testing Client Test Request
celiac_disease_diagnostic_testing_algorithm.pdf
08/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Celiac Disease Diagnostic Testing Algorithm Testing for selective IgA deficiency IGA / Immunoglobulin A (IgA), Serum TTGA / Tissue...
Melanoma panel provides more tumor information - Insights
In this test specific episode of the "Answers From the Lab" podcast, Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' comprehensive melanoma panel better informs prognosis and treatment.
Comprehensive panel boosts GIST diagnosis sensitivity - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
Patient Information and Signature Forms - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Patient Information and Signature Forms - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Mayo Clinic Laboratory and Pathology Research Roundup: May 28 - Insights
This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
@2021 Mayo Foundation for Medical Education and Research Framework for Quality Updated: 12/13/2024 Mayo Clinic Laboratories measure quality not simply by accreditation and licensure, but also by how efficiently esoteric laboratory...
Monoclonal Gammopathy Informative Cases - Insights
Mayo Clinic Laboratories provides evaluation and consultation for the diagnosis and treatment of patients with hereditary and acquired hematologic disorders.
MCL Genetics Whole Genome Sequencing Flyer MC2775658
MCL Genetics Genome Sequencing Flyer GENOME SEQUENCING COMPREHENSIVE GENETIC TESTING ADVANCE DIAGNOSIS Clinic Laboratories genome sequencing WGS test utilizes generation
Due to a pending winter storm affecting the FedEx hub in Memphis, Tennessee, and the UPS hub in Louisville, Kentucky, Mayo Clinic Laboratories will monitor and track the situation with our logistics partners to minimize challenges. Read...
In a recent issue of Mayo Clinic's Digestive Diseases, Michael Camilleri, M.D., a gastroenterologist at Mayo Clinic, and Leslie Donato, Ph.D., Co-Director for Cardiovascular Laboratory Medicine, Hospital Clinical Laboratory, and Point of...
Mayo Clinic Laboratory and pathology research roundup: September 26 - Insights
This week's research roundup feature: Semaglutide in HFpEF across obesity class and by body weight reduction.
Alzheimer's Disease 2024: The Role of Biomarkers - Insights
PACE/State of FL - The latest updates in Alzheimer’s disease diagnostic criteria as well as a comprehensive review of the laboratory testing landscape.
Liquid biopsy cancer testing - Insights
Learn how the pioneering approach used in liquid biopsy testing available through Mayo Clinic Laboratories enables individualized insights that drive personalized care.
Commercial laboratories partners have access to Mayo Clinic Laboratories full menu of subspecialty testing, which spans the spectrum of medical specialties.
Mayo Clinic Laboratory and Pathology Research Roundup: May 7 - Insights
This week’s Research Roundup highlights how fasting blood-glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis.
Mayo Clinic Laboratory and Pathology Research Roundup: December 26 - Insights
This week's research roundup feature: Histoplasma and Blastomyces antigen detection assays are commonly used diagnostic tools. However, a high level of cross-reactivity between these antigens prevents definitive pathogen identification by...
We offer next-generation sequencing and comprehensive fluorescence in situ hybridization (FISH) panels, as well as extensive immunohistochemistry (IHC) offerings, to diagnose and monitor T-cell lymphoma.
Learn about our full suite of leukemia testing protocols, including includes flow cytometry, chromosome, FISH, and molecular testing.
Mayo Clinic Laboratory and Pathology Research Roundup: March 12 - Insights
This week's research roundup feature: C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the alternative pathway of complement. C3G includes C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), both of which...
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 20 - Insights
This week’s Research Roundup highlights how fasting blood glucose levels provide an estimate of duration and progression of pancreatic cancer before diagnosis.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 26 - Insights
This week’s Research Roundup highlights the effect of inorganic nitrite versus a placebo on exercise capacity among patients with heart failure with preserved ejection fraction.
Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC, describe how Mayo Clinic Laboratories' postmortem genetic tests can provide answers after a sudden unexplained cardiac death. Test results are important for managing family members' risk...
glucose-6-phosphate-dehydrogenase-genotyping-interpretive-algorithm.pdf
In the following situations, order G6PDZ / Glucose-6-Phosphate Dehydrogenase (G6PD) Full Gene Sequencing: ■ To determine carrier status (female patient) or affected status (male patient) ■ Previous G6PD enzyme test result is...
Learn more about our comprehensive menu of COVID-19 molecular, serology, and related testing.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Dementia with Lewy bodies, Parkinson's, and multiple system atrophy - Insights
Learn more about how Mayo Clinic Laboratories' cerebrospinal fluid biomarker test for synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, can accurately identify α-syn pathology even before definitive symptoms...
Demyelinating neuropathies - Insights
Learn how our expert-backed testing can increase confidence when it comes to the identification of several demyelinating neuropathies.
Hereditary epilepsy - Insights
Find out how we perform in-depth mutation and copy number variant analysis to determine causes of epilepsy and identify potential treatment options.
https://news.mayocliniclabs.com/file-ai-antibody-matrix/
The evolution of phenotype-specific antibody testing Autoimmune neurology testing is rapidly evolving, with increasing numbers of clinically relevant biomarkers discovered each year. Mayo Clinic’s Neuroimmunology Laboratory has developed...
Mayo Clinic Laboratories’ comprehensive menu of genetic cardiovascular testing provides results that support gene-based strategies to manage inherited cardiovascular disease.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 18 - Insights
This week’s Research Roundup highlights Mayo Clinic researchers who conducted a study to characterize the clinical, pathologic, and survival implications of non-V600 BRAF mutations in metastatic colorectal cancer.